3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 1/2
2
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Diseases
1
Advanced HR - Positive, HER2 - Negative Breast Cancer
1
Interventions
Exercise
2
pyrotinib
1
palbociclib
1
Trastuzumab
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Surgimend
1
Paclitaxel
1
Mammaplasty
1
Liquid Biopsy
1
Fentanyl
1
Epirubicin
1
Educational Status
1
Docetaxel
1
Cyclophosphamide
1
Cryotherapy
1
Cholecalciferol
1
Carboplatin
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Breast Diseases
×
palbociclib
×
Clear all
NCT03756090
2018-12-07
PECP
Zhejiang Cancer Hospital
Phase NA
Unknown
100 enrolled